The Committee for Medicinal Products for Human Use (CHMP) is the European Medicines Agency body responsible for evaluating medicines for the EU market.
CHMP issues scientific opinions on marketing authorization applications. Its expectations influence trial endpoints, benefitñrisk assessment, and safety reporting. Sponsors conducting global trials often align protocols to meet both CHMP and FDA requirements.